Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OFD1 pseudogene 2 Y-linked is annotated as a pseudogene related to the OFD1 gene family and located on the human Y chromosome[3]. Unlike its functional counterparts such as the X-linked OFD1 gene, which plays a crucial role in development and is associated with oral-facial-digital syndrome and neurodevelopmental disorders[1][2], OFD1P2Y does not encode a known functional protein product nor has it been established as a therapeutic target or biomarker. Current genomic resources and studies identify this locus as a pseudogene, indicating a lack of canonical transcriptional or translational activity in humans. Although the broader OFD1 gene family contains crucial functional members implicated in disease, there is no evidence that OFD1P2Y itself is involved in drug interactions, clinical biomarker applications, or direct disease mechanisms[3][1]. Its main relevance is phylogenetic and evolutionary, and the presence of similar pseudogenes or relics on the Y chromosome is a feature of gene family evolution, rather than of clinical or therapeutic interest[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on OFD1 pseudogene 2 Y-linked (OFD1P2Y).